PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 39 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

2 July 2025

  1. (diff | hist) 09:15 Talk:Qingdao Saber Technology Pharmaceutical 822 +67 DisambigDenzil (talk | contribs) /* Two organisations, one city, similar names */ reply
  2. (diff | hist) N 09:00 Shanghai ERP Biotechnology 1,729 +1,729 LedgerLysander (talk | contribs) start organisation article — registry facts and product scope only
  3. (diff | hist) 05:21 Sterility testing 4,438 +775 Chromatokid (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 00:04 Injection site rotation 4,626 +562 eGFR_Esme (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]

1 July 2025

  1. (diff | hist) m 22:22 Prescribing information 4,364 ±0 AnalyticalAnnie (talk | contribs) fix indentation in the source [rollback]
  2. (diff | hist) 12:09 Triple agonist 3,987 ±0 CustomsClarke (talk | contribs) add see also to the amylin analogue [rollback]
  3. (diff | hist) m 09:37 Prior authorisation 3,517 ±0 PatientPanelPru (talk | contribs) state that the pricing data is self-reported where it is [rollback]
  4. (diff | hist) 09:03 Talk:Vial 959 +140 SigFigSindri (talk | contribs) /* Overflow capacities in the R-series table */ reply
  5. (diff | hist) 08:44 Talk:Blind sampling 1,096 +162 ChainCustodyChad (talk | contribs) /* Anonymous ordering: does it count as blinding? */ reply

30 June 2025

  1. (diff | hist) 22:28 Wuhan Wansheng Biotechnology 13,250 +1,017 SecondarySrc_Seb (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  2. (diff | hist) m b 18:29 SinoPep 3,724 +747 CategoryBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  3. (diff | hist) 18:06 Peptide synthesis 4,967 ±0 CDMO_Caradoc (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  4. (diff | hist) 17:11 Talk:Vial 748 +325 StopperingSteff (talk | contribs) /* Overflow capacities in the R-series table */ reply
  5. (diff | hist) 16:48 Chinese Peptide Company 13,089 ±0 DiffWatchDov (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  6. (diff | hist) 15:54 Peptide content 8,131 +1,206 LiraLotte (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  7. (diff | hist) 14:55 Talk:Blind sampling 885 +194 BlindSampleBrid (talk | contribs) /* Anonymous ordering: does it count as blinding? */ reply
  8. (diff | hist) 14:26 Talk:Vial 537 +329 SigFigSindri (talk | contribs) /* Overflow capacities in the R-series table */ new section
  9. (diff | hist) 14:10 Customs seizure 3,672 +28 ImportPolicyIggy (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  10. (diff | hist) 13:27 Talk:Qingdao Saber Technology Pharmaceutical 611 +154 NPOV_Nadia (talk | contribs) /* Two organisations, one city, similar names */ reply
  11. (diff | hist) m 11:45 Zhuhai Kerui Biotechnology 4,713 +519 ForgeryFinder (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  12. (diff | hist) 11:21 Talk:Blind sampling 674 +129 GroupBuyGalen (talk | contribs) /* Anonymous ordering: does it count as blinding? */ new section
  13. (diff | hist) 10:55 Flourishglobal Peptide Biotech 7,214 +330 B12_Bettina (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  14. (diff | hist) 10:52 Talk:Qingdao Saber Technology Pharmaceutical 400 +224 DisambigDenzil (talk | contribs) /* Two organisations, one city, similar names */ new section
  15. (diff | hist) 07:25 Weight regain after discontinuation 4,624 ±0 GastroparesisGwen (talk | contribs) consistent en dashes in ranges [rollback]
  16. (diff | hist) 00:16 Contract development and manufacturing organisation 4,240 +24 RepackRadek (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]

29 June 2025

  1. (diff | hist) m 22:52 Medutest 4,669 ±0 SecondarySrc_Seb (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) m 19:35 Hubei Jianxiang Bioscience 7,008 +899 BatchNumberBede (talk | contribs) ce [rollback]
  3. (diff | hist) 08:41 WuXi TIDES 13,639 +1,712 BlankVialBo (talk | contribs) split overlong sentence [rollback]
  4. (diff | hist) m 02:58 Research use only 7,423 ±0 GsCouplingGil (talk | contribs) rm the speculation about future scheduling [rollback]
  5. (diff | hist) 01:38 Dose escalation schedule 4,096 +23 NurseNoteNessa (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  6. (diff | hist) 01:08 Dulaglutide 5,130 ±0 OralSemaOswin (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  7. (diff | hist) 00:47 SURPASS trial programme 5,078 +604 ParentCatPansy (talk | contribs) split the results table so the two doses are separate rows [rollback]

28 June 2025

  1. (diff | hist) 21:22 Chain of custody 4,708 ±0 SigFigSindri (talk | contribs) alphabetise the see-also list [rollback]
  2. (diff | hist) m 17:40 International nonproprietary name 4,000 ±0 NAION_Noel (talk | contribs) expand §Practical use [rollback]
  3. (diff | hist) m b 17:23 Body composition assessment 4,416 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  4. (diff | hist) m 14:42 SUSTAIN trial programme 4,728 ±0 EndpointEnid (talk | contribs) convert a hard-coded date to the house format [rollback]
  5. (diff | hist) 13:37 ISO 9001 3,898 +519 AnalyticalAnnie (talk | contribs) add the note that this wiki does not give legal advice [rollback]
  6. (diff | hist) 12:25 Vial filling and stoppering 4,012 ±0 PrepHPLC_Pia (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  7. (diff | hist) 09:26 Reconstitution of lyophilised peptides 5,243 ±0 SubQ_Solveig (talk | contribs) rm a duplicated category [rollback]
  8. (diff | hist) m 05:41 Third-party testing 6,906 ±0 IncretinIvo (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

27 June 2025

  1. (diff | hist) m 23:40 Trial data comparison 5,621 +173 ConsensusConal (talk | contribs) correct the dead-space assumption in the doses-per-vial figure [rollback]
  2. (diff | hist) m 22:44 VendorInvestigate 4,918 ±0 BatchNumberBede (talk | contribs) state that the report identifies the sample, not the shipment [rollback]
  3. (diff | hist) 19:51 ChinaPeptides 9,996 +485 BalanceBirdie (talk | contribs) expand §Reception [rollback]
  4. (diff | hist) m b 17:02 Growth hormone secretagogue 4,495 +875 CiteBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 10:18 Talk:Trial data comparison 1,170 +100 PuffRemoverPax (talk | contribs) /* Should the bars be there at all? */ reply
  6. (diff | hist) m 04:37 Sigma-Aldrich (Shanghai) Trading 8,283 +645 DPP4_Dagmar (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  7. (diff | hist) 00:27 Qingdao Saber Technology Pharmaceutical 3,239 +747 ReportReaderRilla (talk | contribs) move a stray full stop inside the reference [rollback]

26 June 2025

  1. (diff | hist) 22:48 Adverse effects of GLP-1 receptor agonists 5,791 +477 BiliaryBea (talk | contribs) expand §Gastrointestinal effects [rollback]
  2. (diff | hist) 21:07 Cold chain 22,602 +300 VerifyFirstVida (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  3. (diff | hist) 16:47 Underfilling 3,863 ±0 HedgeHedda (talk | contribs) ce, tighten prose [rollback]
  4. (diff | hist) m 16:28 Janoshik Analytical 5,235 +236 ForgeryFinder (talk | contribs) expand §Interpreting a chromatogram [rollback]
  5. (diff | hist) m 15:04 High-performance liquid chromatography 6,203 ±0 ReceptorRhoda (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  6. (diff | hist) m b 12:08 GLP-1 receptor 7,149 +118 StubSorterBot (talk | contribs) bot: expand PMID to full citation [rollback]
  7. (diff | hist) 06:36 Peptide aggregation 5,194 +817 PortalPolly (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  8. (diff | hist) m 01:04 C-peptide 4,233 ±0 CRP_Cormac (talk | contribs) add the sample-stability sentence with its storage condition [rollback]
  9. (diff | hist) m 00:14 Personal importation policy 3,773 +522 ColdChainCleo (talk | contribs) add the jurisdiction to the legal statement [rollback]

25 June 2025

  1. (diff | hist) 21:36 Amylin receptor agonist 4,965 +1,038 IcodecIndra (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  2. (diff | hist) 20:43 Temperature excursion 10,953 +836 RetatrutideRuben (talk | contribs) expand §Assessment and disposition [rollback]
  3. (diff | hist) 12:43 Counterfeit peptide 4,235 ±0 OrforglipronOona (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  4. (diff | hist) 09:52 Talk:Trial data comparison 959 +236 ForestPlotFinn (talk | contribs) /* Should the bars be there at all? */ reply
  5. (diff | hist) 08:26 Talk:Hunan Aslsen Technology 959 +217 GradientGus (talk | contribs) /* Area percent on non-peptide lines */ reply
  6. (diff | hist) 06:51 Good manufacturing practice 4,901 ±0 ImportPolicyIggy (talk | contribs) space between number and unit per PP:MOS [rollback]
  7. (diff | hist) m 05:34 Beta cell function 5,751 ±0 LyophilLena (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]

24 June 2025

  1. (diff | hist) 22:43 Cold-chain freight 4,370 +671 SupplyWatchSuri (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  2. (diff | hist) m 22:21 Subcutaneous injection 4,640 ±0 FiveOhThreeB (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  3. (diff | hist) 15:29 Talk:Trial data comparison 748 +329 DataTableDunja (talk | contribs) /* Should the bars be there at all? */ reply
  4. (diff | hist) 13:53 Test report forgery 5,055 +852 ColumnOvenCoy (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  5. (diff | hist) 13:48 USP General Chapter 85 4,295 +25 IsocraticIla (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  6. (diff | hist) 13:13 Dual incretin agonist 5,366 +614 Areapercent_Ayo (talk | contribs) state which salt form the mass in the infobox refers to [rollback]
  7. (diff | hist) 13:07 Talk:Hunan Aslsen Technology 748 +218 ChromCleanupCass (talk | contribs) /* Area percent on non-peptide lines */ reply
  8. (diff | hist) 13:03 Electrospray ionisation 4,073 ±0 NewLabNell (talk | contribs) expand §Mechanism [rollback]
  9. (diff | hist) 11:07 Talk:Trial data comparison 537 +203 PuffRemoverPax (talk | contribs) /* Should the bars be there at all? */ new section
  10. (diff | hist) 09:41 Talk:Hunan Aslsen Technology 537 +314 AnalyticalAnnie (talk | contribs) /* Area percent on non-peptide lines */ new section
  11. (diff | hist) 09:35 SinoPep 2,977 +38 COA_Colwyn (talk | contribs) add category for suppliers in China [rollback]
  12. (diff | hist) 08:09 Vial 21,712 +1,439 NPOV_Nadia (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  13. (diff | hist) 07:14 Shanghai Sigma-Audley New Material Technology 10,600 +965 Retention_Time_Rae (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  14. (diff | hist) 01:12 Global access disparity 3,508 ±0 PioneerPerdita (talk | contribs) unpipe a link that did not need piping [rollback]

23 June 2025

  1. (diff | hist) 21:25 Peptide harm reduction 3,975 ±0 TrialsTabitha (talk | contribs) state the exchange rate and its date [rollback]
  2. (diff | hist) m 20:32 Aspiration risk under anaesthesia 4,377 +466 LeanMassLars (talk | contribs) expand §Interpretation [rollback]
  3. (diff | hist) m 18:42 MOTS-c 3,596 ±0 GHK_Gwendolen (talk | contribs) label the secretagogue claim as receptor-level, not clinical [rollback]
  4. (diff | hist) 15:50 Bacteriostatic water 4,541 ±0 CommaCarys (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  5. (diff | hist) m 14:26 Multi-dose vial 16,561 +721 SemaglutideSasha (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  6. (diff | hist) 11:56 Tirzepatide 7,922 +149 CuriousCallum (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  7. (diff | hist) m b 11:24 FLOW trial 4,414 ±0 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  8. (diff | hist) 05:15 Lot traceability 4,777 ±0 MetricMabel (talk | contribs) rm the inference from one report to a supplier [rollback]
  9. (diff | hist) m b 01:30 Residual solvent 4,161 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]

22 June 2025

  1. (diff | hist) m b 20:52 Amino acid analysis 4,038 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) 14:52 Retatrutide 5,894 ±0 Peptide_Pete (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  3. (diff | hist) m 14:01 Mass spectrometry 5,612 ±0 GradientGus (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  4. (diff | hist) m 11:24 Insulin secretion 6,373 ±0 AnalyticalAnnie (talk | contribs) expand §Failure in type 2 diabetes [rollback]
  5. (diff | hist) 10:11 Amylin 4,449 +172 TirzTaxonomist (talk | contribs) add the peptide length to the infobox [rollback]
  6. (diff | hist) 08:56 Certificate of analysis 8,863 +270 MassSpecMarv (talk | contribs) add the turnaround time the service publishes [rollback]
  7. (diff | hist) 08:21 Melanotan II 3,724 ±0 IpamorelinIsold (talk | contribs) clarify that the compound is sold as an acetate salt [rollback]
  8. (diff | hist) 03:08 Sterile water for injection 4,413 ±0 NurseNoteNessa (talk | contribs) fix a broken wikilink [rollback]
  9. (diff | hist) m 02:36 Peptide supply chain 7,636 ±0 SPPS_Sorrel (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  10. (diff | hist) m 02:00 Albumin binding half-life extension 6,021 ±0 BlankVialBo (talk | contribs) fix a broken wikilink [rollback]
  11. (diff | hist) 01:22 Timeline of incretin therapeutics 4,460 +468 OralSemaOswin (talk | contribs) expand §Second generation and beyond [rollback]

21 June 2025

  1. (diff | hist) m b 21:13 Nantong Guangyuan Chemical 13,128 +2,510 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) m b 20:56 Orforglipron 4,505 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) m 20:03 Lixisenatide 4,057 +23 LCellLeif (talk | contribs) give the INN alongside the trade name at first mention [rollback]